In the pharmaceutical industry, drug delivery presents several challenges to find the safest, fastest, and reliable way to administer drugs. Cutaneous administration represents a convenient route due.
How a drug — more precisely an active pharmaceutical ingredient (API) — is taken up by the body and delivered to the site of disease, has a tremendous effect on the efficacy of the API itself..
The current developments around the application of metal-organic frameworks (MOFs) for pharmaceutical and biomedical applications are forcing us to have a closer look at how harmful they are. In.
Starting with the first publication about metal-organic frameworks (MOFs) in 1999, MOFs have seen a rapid growth in the last years and have proven to be of great interest to the pharmaceutical.